2007

• Shah M, Adams-Huet B, Garg A.
  Effect of high-carbohydrate or high-cis-monounsaturated fat diets on blood pressure: a meta-analysis of intervention trials.
  Am J Clin Nutr. 2007 May;85(5):1251-6.
  
• Garg A, Simha V.
  Update on Dyslipidemia.
  J Clin Endocrinol Metab. 2007 May;92(5):1581-1589.
• Pan Y, Garg A, Agarwal AK.
  Mislocalization of prelamin A Tyr646Phe mutant to the nuclear pore complex in human embryonic kidney 293 cells.
  Biochem Biophys Res Commun. 2007 Mar 30;355(1):78-84. Epub 2007 Jan 31.

2006

• Shah M, Simha V, Garg A.
  Review: long-term impact of bariatric surgery on body weight, comorbidities, and nutritional status.
  J Clin Endocrinol Metab. 2006 Nov;91(11):4223-31. Epub 2006 Sep 5. Review.
• Agarwal AK, Barnes RI, Garg A.
  Functional characterization of human 1-acylglycerol-3-phosphate acyltransferase isoform 8: cloning, tissue distribution, gene structure, and enzymatic activity.
  Arch Biochem Biophys. 2006 May 15;449(1-2):64-76. Epub 2006 Mar 29.
• Simha V, Garg A.
  Lipodystrophy: lessons in lipid and energy metabolism.
  Curr Opin Lipidol. 2006 Apr;17(2):162-9. Review.
• Jacob KN, Garg A.
  Laminopathies: multisystem dystrophy syndromes.
  Mol Genet Metab. 2006 Apr;87(4):289-302. Epub 2005 Dec 20. Review. Erratum in: Mol Genet Metab. 2006 Aug;88(4):391.
• Van Esch H, Agarwal AK, Debeer P, Fryns JP, Garg A.
  A homozygous mutation in the lamin A/C gene associated with a novel syndrome of arthropathy, tendinous calcinosis, and progeroid features.
  J Clin Endocrinol Metab. 2006 Feb;91(2):517-21. Epub 2005 Nov 8.
• Agarwal AK, Garg A.
  Genetic disorders of adipose tissue development, differentiation, and death.
  Annu Rev Genomics Hum Genet. 2006;7:175-99.
• Agarwal AK, Garg A.
  Genetic basis of lipodystrophies and management of metabolic complications.
  Annu Rev Med. 2006;57:297-311. Review.

2005

• Shah M, Adams-Huet B, Bantle JP, Henry RR, Griver KA, Raatz SK, Brinkley LJ, Reaven GM, Garg A.
  Effect of a high-carbohydrate versus a high--cis-monounsaturated fat diet on blood pressure in patients with type 2 diabetes.
  Diabetes Care. 2005 Nov;28(11):2607-12.
• Garg A, Cogulu O, Ozkinay F, Onay H, Agarwal AK.
  A novel homozygous Ala529Val LMNA mutation in Turkish patients with mandibuloacral dysplasia.
  J Clin Endocrinol Metab. 2005 Sep;90(9):5259-64. Epub 2005 Jul 5. Review.
• Shah M, Tierney K, Adams-Huet B, Boonyavarakul A, Jacob K, Quittner C, Dinges W, Peterson D, Garg A.
  The role of diet, exercise and smoking in dyslipidaemia in HIV-infected patients with lipodystrophy.
  HIV Med. 2005 Jul;6(4):291-8.
• Haque W, Garg A, Agarwal AK.
  Enzymatic activity of naturally occurring 1-acylglycerol-3-phosphate-O-acyltransferase 2 mutants associated with congenital generalized lipodystrophy.
  Biochem Biophys Res Commun. 2005 Feb 11;327(2):446-53.
• Dinges WL, Chen D, Snell PG, Weatherall PT, Peterson DM, Garg A.
  Regional body fat distribution in HIV-infected patients with lipodystrophy.
  J Investig Med. 2005 Jan;53(1):15-25.
• Agarwal AK, Garg A.
  Seipin: a mysterious protein.
  Trends Mol Med. 2004 Sep;10(9):440-4. Review. No abstract available.

2004

• Garg A.
  Statins for all patients with type 2 diabetes: not so soon.
  Lancet. 2004 Aug 21-27;364(9435):641-2. No abstract available.
• Garg A, Misra A.
  Lipodystrophies: rare disorders causing metabolic syndrome.
  Endocrinol Metab Clin North Am. 2004 Jun;33(2):305-31. Review.
• Garg A.
  Acquired and inherited lipodystrophies.
  N Engl J Med. 2004 Mar 18;350(12):1220-34. Review. No abstract available.
• Haque WA, Garg A.
  Adipocyte biology and adipocytokines.
  Clin Lab Med. 2004 Mar;24(1):217-34. Review.
• Agarwal AK, Barnes RI, Garg A.
  Genetic basis of congenital generalized lipodystrophy.
  Int J Obes Relat Metab Disord. 2004 Feb;28(2):336-9. Review.

2003

• Agarwal AK.
  Cortisol metabolism and visceral obesity: role of 11beta-hydroxysteroid dehydrogenase type I enzyme and reduced co-factor NADPH.
  Endocr Res. 2003 Nov;29(4):411-8. Review.
• Simha V, Garg A.
  Phenotypic heterogeneity in body fat distribution in patients with congenital generalized lipodystrophy caused by mutations in the AGPAT2 or seipin genes.
  J Clin Endocrinol Metab. 2003 Nov;88(11):5433-7.
• Agarwal AK, Simha V, Oral EA, Moran SA, Gorden P, O'Rahilly S, Zaidi Z, Gurakan F, Arslanian SA, Klar A, Ricker A, White NH, Bindl L, Herbst K, Kennel K, Patel SB, Al-Gazali L, Garg A.
  Phenotypic and genetic heterogeneity in congenital generalized lipodystrophy.
  J Clin Endocrinol Metab. 2003 Oct;88(10):4840-7.
• Agarwal AK, Fryns JP, Auchus RJ, Garg A.
  Zinc metalloproteinase, ZMPSTE24, is mutated in mandibuloacral dysplasia.
  Hum Mol Genet. 2003 Aug 15;12(16):1995-2001.
• Agarwal AK, Garg A.
  Congenital generalized lipodystrophy: significance of triglyceride biosynthetic pathways.
  Trends Endocrinol Metab. 2003 Jul;14(5):214-21. Review.
• Simha V, Agarwal AK, Oral EA, Fryns JP, Garg A.
  Genetic and phenotypic heterogeneity in patients with mandibuloacral dysplasia-associated lipodystrophy.
  J Clin Endocrinol Metab. 2003 Jun;88(6):2821-4.
• Haque WA, Oral EA, Dietz K, Bowcock AM, Agarwal AK, Garg A.
  Risk factors for diabetes in familial partial lipodystrophy, Dunnigan variety.
  Diabetes Care. 2003 May;26(5):1350-5.
• Misra A, Garg A.
  Clinical features and metabolic derangements in acquired generalized lipodystrophy: case reports and review of the literature.
  Medicine (Baltimore). 2003 Mar;82(2):129-46. Review.
• Simha V, Szczepaniak LS, Wagner AJ, DePaoli AM, Garg A.
  Effect of leptin replacement on intrahepatic and intramyocellular lipid content in patients with generalized lipodystrophy.
  Diabetes Care. 2003 Jan;26(1):30-5.

2002

• Haque WA, Vuitch F, Garg A.
  Post-mortem findings in familial partial lipodystrophy, Dunnigan variety.
  Diabet Med. 2002 Dec;19(12):1022-5.
• Simha V, Zerwekh JE, Sakhaee K, Garg A.
  Effect of subcutaneous leptin replacement therapy on bone metabolism in patients with generalized lipodystrophy.
  J Clin Endocrinol Metab. 2002 Nov;87(11):4942-5.
• Chen D, Misra A, Garg A.
  Clinical review 153: Lipodystrophy in human immunodeficiency virus-infected patients.
  J Clin Endocrinol Metab. 2002 Nov;87(11):4845-56. Review.
• Haque WA, Shimomura I, Matsuzawa Y, Garg A.
  Serum adiponectin and leptin levels in patients with lipodystrophies.
  J Clin Endocrinol Metab. 2002 May;87(5):2395.
• Simha V, Garg A.
  Body fat distribution and metabolic derangements in patients with familial partial lipodystrophy associated with mandibuloacral dysplasia.
  J Clin Endocrinol Metab. 2002 Feb;87(2):776-85.
• Agarwal AK, Garg A.
  A novel heterozygous mutation in peroxisome proliferator-activated receptor-gamma gene in a patient with familial partial lipodystrophy.
  J Clin Endocrinol Metab. 2002 Jan;87(1):408-11.
  

Book Chapters

• Barnett JP, Garg A.
  Preventing cardiovascular complications in diabetes. In: Carson JA, Burke FM, Hark LA (eds). Cardiovascular Nutrition: Disease Management and Prevention.
  American Dietetic Association, Chicago, IL. pp 189-211.
  
  
• Garg A.
  Lipodystrophic syndromes. Meet-The-Professor Handouts: The Endocrine Society Press. Bethesda, MD. pp 165-170, 2004.
  
  
• Garg A.
  Lipodystrophy epidemiology and new syndromes. In Proceedings of the International Congress of Endocrinology, Elsevier. 2004 (in press).